Pacira BioSciences, Inc.

PCRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001396814

SEC filings (opens in a new tab)

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Pacira BioSciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of PCRX: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	233	1	239	+7
Shares	50.5M	5	48.0M	−2.57M (−5.1%)
Value	$1.21B	$0	$1.24B	+$28.3M (+2.3%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Pacira BioSciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to PCRX in Q3 2025
Institution	Shares	Value	% of portfolio
Adage Capital Partners GP, L.L.C.	409,997	$10.6M	0.02%
AXA Investment Managers S.A.	117,285	$3.02M	0.01%
HRT Financial LP	108,459	$2.79M	0.01%
Hussman Strategic Advisors, Inc.	105,000	$2.71M	0.59%
Exchange Traded Concepts, LLC	75,598	$1.95M	0.02%
Citadel Advisors LLC	71,178	$1.83M	0.00%
Trexquant Investment LP	60,096	$1.55M	0.02%
ExodusPoint Capital Management, LP	58,290	$1.50M	0.02%
Radcliffe Capital Management, L.P.	47,589	$1.23M	0.08%
Jump Financial, LLC	20,458	$527.2K	0.01%
Quantbot Technologies LP	20,408	$525.9K	0.01%
Capstone Investment Advisors, LLC	19,171	$494.0K	0.00%
Tudor Investment Corp Et Al	18,637	$480.3K	0.00%
Qube Research & Technologies Ltd	16,307	$420.2K	0.00%
Foster & Motley Inc	15,073	$388.0K	0.02%
HighTower Advisors, LLC	13,170	$339.4K	0.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management	12,957	$333.9K	0.01%
Toth Financial Advisory Corp	12,000	$309.2K	0.03%
First Trust Advisors LP	9,742	$251.1K	0.00%
OP Asset Management Ltd	9,188	$236.8K	0.00%
Caitlin John, LLC	4,205	$108.4K	0.08%
Vestcor Inc	3,504	$90.0K	0.00%
ISAM Funds (UK) Ltd	3,087	$79.6K	0.02%
Tidemark, LLC	2,169	$55.9K	0.02%
Rockefeller Capital Management L.P.	1,871	$48.2K	0.00%
Quadrant Capital Group LLC	555	$14.3K	0.00%
Salomon & Ludwin, LLC	334	$8.30K	0.00%
Advisory Services Network, LLC	232	$5.98K	0.00%
Optiver Holding B.V.	218	$5.62K	0.00%
Harbor Capital Advisors, Inc.	183	$5.00K	0.00%
Caldwell Sutter Capital, Inc.	149	$3.84K	0.00%
CoreCap Advisors, LLC	144	$3.71K	0.00%
Assetmark, Inc	31	$799	0.00%
Wealthspire Advisors, LLC	28	$722	0.00%
Northwestern Mutual Wealth Management Co	25	$644	0.00%
Financial Consulate, Inc	10	$258	0.00%
Binnacle Investments Inc	8	$206	0.00%

Sold out (30)

Institutions that held Pacira BioSciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of PCRX in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Polar Capital Holdings Plc	910,455	$21.8M
EcoR1 Capital, LLC	457,471	$10.9M
Siren, L.L.C.	225,000	$5.38M
Alyeska Investment Group, L.P.	200,846	$4.80M
Marshall Wace, LLP	190,366	$4.55M
Susquehanna International Group, LLP	123,087	$2.94M
AXA S.A.	117,285	$2.80M
Winton Group Ltd	102,668	$2.45M
Raymond James Financial Inc	90,108	$2.15M
Verition Fund Management LLC	27,662	$661.1K
Man Group plc	26,302	$628.6K
Maryland State Retirement & Pension System	13,488	$322.4K
Numerai GP LLC	12,293	$293.8K
Los Angeles Capital Management LLC	11,475	$274.3K
Integrated Quantitative Investments LLC	10,379	$248.1K
Bank of Montreal	9,435	$225.5K
Neuberger Berman Group LLC	8,382	$200.3K
Meeder Asset Management Inc	3,227	$77.1K
Skopos Labs, Inc.	1,686	$40.3K
Simplex Trading, LLC	1,598	$38.0K
Loring Wolcott & Coolidge Fiduciary Advisors LLP	400	$9.56K
Geneos Wealth Management Inc.	363	$8.68K
Group One Trading, L.P.	357	$8.53K
Danske Bank A/S	223	$5.33K
Aster Capital Management (DIFC) Ltd	212	$5.07K
Twin Peaks Wealth Advisors, LLC	105	$2.60K
Park Square Financial Group, LLC	85	$2.03K
Elequin Capital LP	39	$932
Annis Gardner Whiting Capital Advisors, LLC	8	$192
Larson Financial Group LLC	6	$143

Not filed for Q3 2025 yet (1)

Institutions that held Pacira BioSciences, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCRX in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
PrairieView Partners, LLC	5	$0